Barr Pharmaceuticals gets tentative OK for generic Effexor
June 26 (Reuters) - Barr Pharmaceuticals Inc. (BRL.N: Quote, Profile, Research, Stock Buzz) said its unit, PLIVA, got tentative approval from U.S. regulators for its generic version of Wyeth Pharmaceuticals Inc.'s anti-depressant, Effexor.
The company expects to receive final approval upon the expiration of the pediatric exclusivity of Wyeth's patent on June 13, 2008. (Reporting by Neetha Mahadevan in Bangalore)
© Thomson Reuters 2008 All rights reserved
Help us advance this story. Provide relevant links or share your insights using our comment box. Please be considerate and help us by reporting any abuse you find. Reuters will delete comments that don't meet community standards.
Have a correction to this article? Email the editors
Obama's economic stimulus plan